I-Mab (NASDAQ:IMAB) Earns Buy Rating from Needham & Company LLC
I-Mab (NASDAQ:IMAB – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at Needham & Company LLC in a research note issued to investors on Friday,Benzinga reports. They presently have a $4.00 price objective on the stock. Needham & Company LLC’s price objective points to a potential upside of 488.24% from the […]
